Home > Riviste > Panminerva Medica > Fascicoli precedenti > Panminerva Medica 2016 September;58(3) > Panminerva Medica 2016 September;58(3):237-41

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Estratti
Permessi
Per citare questo articolo
Share

 

REVIEWS   

Panminerva Medica 2016 September;58(3):237-41

Copyright © 2016 EDIZIONI MINERVA MEDICA

lingua: Inglese

Pathogenesis and treatment options for intradialytic hypertension

Ana ROCHA

São Francisco Dialysis Unit, Porto, Portugal


PDF


Controversy surrounds the diagnosis and treatment of intradialytic hypertension. Here, we describe the definition, epidemiology and management of intradialytic hypertension. Although this hemodialysis complication has long been recognized, only recently it was associated with increased morbidity and mortality in dialysis patients. Endothelial cell dysfunction appears to be the major mechanism underlying this blood pressure phenomenon, and the role of extracellular volume and sodium overload remains to be better defined. To treat this potential cardiovascular health threat is necessary to identify and understand the factors that influence it.

inizio pagina